Story Highlights Inovio Pharmaceuticals has started Phase 1 testing of its experimental COVID-19 DNA vaccine in healthy volunteers. The U.S. biotech firm has already produced enough of the vaccine to support Phase 1 (immune system reactivity and safety) and Phase 2 (efficacy) testing and plans to have one million doses ready for distribution by the […]
Vaccine developers at the University of Pittsburgh’s Center for Vaccine Research (CVR) have taken a part of the coronavirus involved in COVID-19 infection and attached it to a genetically modified measles vaccine that has been used for many years.1 According to CVR Director Dr. Paul Duprex, “CVR has a mandated role to respond rapidly to […]
Story Highlights Another attempt to create an effective vaccine against the Human Immunodeficiency Virus (HIV) has been stopped early because it was not found to prevent HIV infection. It is estimated that 1,000 people are newly infected every day in South Africa. HIV virus appears to evade and destroy cells of the immune system and […]
In a lawsuit filed by the state of Oklahoma against Johnson & Johnson, Inc., Purdue Pharma LP and Teva Pharmaceutical Industries Ltd., the pharmaceutical giant Johnson & Johnson and its subsidiaries were ordered on Aug. 26, 2019 to pay $572 million in penalties for helping to fuel the opioid crisis in Oklahoma.1 Before the trial […]
Story Highlights NIH, in collaboration with Johnson & Johnson, will begin HIV vaccine efficacy trials on humans in August 2019 in the U.S. Another HIV vaccine candidate, using a live attenuated herpes cytomegalovirus (CMV), is also nearing clinical trials in humans. There are serious safety concerns regarding live attenuated vaccines and numerous cases reported in […]